ZhiJia Zhang
Thomas Jefferson University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by ZhiJia Zhang.
Nature Structural & Molecular Biology | 2002
Wenyu Li; Srinivasa M. Srinivasula; Jijie Chai; Pingwei Li; Jia-Wei Wu; ZhiJia Zhang; Emad S. Alnemri; Yigong Shi
HtrA2/Omi, a mitochondrial serine protease in mammals, is important in programmed cell death. However, the underlining mechanism of HtrA2/Omi-mediated apoptosis remains unclear. Analogous to the bacterial homolog HtrA (DegP), the mature HtrA2 protein contains a central serine protease domain and a C-terminal PDZ domain. The 2.0 Å crystal structure of HtrA2/Omi reveals the formation of a pyramid-shaped homotrimer mediated exclusively by the serine protease domains. The peptide-binding pocket of the PDZ domain is buried in the intimate interface between the PDZ and the protease domains. Mutational analysis reveals that the monomeric HtrA2/Omi mutants are unable to induce cell death and are deficient in protease activity. The PDZ domain modulates HtrA2/Omi-mediated cell death activity by regulating its serine protease activity. These structural and biochemical observations provide an important framework for deciphering the mechanisms of HtrA2/Omi-mediated apoptosis.
Current Biology | 2002
Srinivasa M. Srinivasula; Pinaki Datta; Masatomo Kobayashi; Jia-Wei Wu; Miki Fujioka; Ramesh Hegde; ZhiJia Zhang; Rula Mukattash; Teresa Fernandes-Alnemri; Yigong Shi; James B. Jaynes; Emad S. Alnemri
Inhibitors of apoptosis proteins (IAPs) interact with caspases and inhibit their protease activity, whereas the IAP-inhibitory proteins Smac/DIABLO in mammals and Reaper, Hid, and Grim in flies relieve IAP-mediated inhibition to induce cell death. Here we describe the functional characterization of the novel Drosophila cell death protein Sickle (Skl), which binds to IAPs and neutralizes their apoptotic inhibitory activity. Skl exhibits no sequence homology to Reaper, Hid, Grim, or Smac/DIABLO, except within the 4 residue N-terminal IAP binding motif. Skl interacts with Drosophila and mammalian IAPs and can promote caspase activation in the presence of IAPs. Consistent with these findings, expression of Skl in Drosophila and mammalian cell lines or in Drosophila embryos induces apoptosis. Skl can also synergize with Grim to induce cell death in the Drosophila eye imaginal disc. Based on biochemical and structural data, the N terminus of Skl, like that of the mammalian Smac/DIABLO, is absolutely required for its apoptotic and caspase-promoting activities and its ability to interact with IAPs. These findings point to conservation in the structure and function of the IAP-inhibitory proteins across species and suggest the existence of other family members.
Journal of Biological Chemistry | 2003
Ramesh Hegde; Srinivasa M. Srinivasula; Pinaki Datta; Muniswamy Madesh; Richard Wassell; ZhiJia Zhang; Naeun Cheong; Julie Nejmeh; Teresa Fernandes-Alnemri; Shin-ichi Hoshino; Emad S. Alnemri
Smac/Diablo and HtrA2/Omi are inhibitors of apoptosis (IAP)-binding proteins released from the mitochondria of human cells during apoptosis and regulate apoptosis by liberating caspases from IAP inhibition. Here we describe the identification of a proteolytically processed isoform of the polypeptide chain-releasing factor GSPT1/eRF3 protein, which functions in translation, as a new IAP-binding protein. In common with other IAP-binding proteins, the processed GSPT1 protein harbors a conserved N-terminal IAP-binding motif (AKPF). Additionally, processed GSPT1 interacts biochemically with IAPs and could promote caspase activation, IAP ubiquitination and apoptosis. The IAP-binding motif of the processed GSPT1 is absolutely required for these activities. Our findings are consistent with a model whereby processing of GSPT1 into the IAP-binding isoform could potentiate apoptosis by liberating caspases from IAP inhibition, or target IAPs and the processed GSPT1 for proteasome-mediated degradation.
Archive | 2002
Jia-Lun Wang; ZhiJia Zhang; Swati Choksi; Simei Shan; Zhixian Lu; Carlo M. Croce; Emad S. Alnemri; Robert Korngold; Ziwei Huang
The potent biological activity of CPM-1285 suggests that it may represent a promising lead for the development of new anticancer agents. The cell permeable Bcl-2 inhibitor can also be used as a chemical probe to study the in vivo mechanism and signaling pathway of the Bcl-2 family. Unlike other peptides that are active only in vitro or in the cell-free system, the cell-permeable peptide approach described here provides a new tool to analyze the function of the Bcl-2 family in living cells and animals.
Proceedings of the National Academy of Sciences of the United States of America | 2000
Jia-Lun Wang; Dongxiang Liu; ZhiJia Zhang; Simei Shan; Xiaobing Han; Srinivasa M. Srinivasula; Carlo M. Croce; Emad S. Alnemri; Ziwei Huang
Journal of Biological Chemistry | 2002
Ramesh Hegde; Srinivasa M. Srinivasula; ZhiJia Zhang; Richard Wassell; Rula Mukattash; Lucia Cilenti; Garrett DuBois; Yuri Lazebnik; Antonis S. Zervos; Teresa Fernandes-Alnemri; Emad S. Alnemri
Journal of Biological Chemistry | 2002
Srinivasa M. Srinivasula; Jean-Luc Poyet; Marjaneh Razmara; Pinaki Datta; ZhiJia Zhang; Emad S. Alnemri
Molecular Cell | 2007
Je-Wook Yu; Teresa Fernandes-Alnemri; Pinaki Datta; Jianghong Wu; Christine Juliana; Leobaldo Solorzano; Margaret McCormick; ZhiJia Zhang; Emad S. Alnemri
Cancer Research | 2000
Jia-Lun Wang; ZhiJia Zhang; Swati Choksi; Simei Shan; Zhixian Lu; Carlo M. Croce; Emad S. Alnemri; Robert Korngold; Ziwei Huang
Journal of Biological Chemistry | 2003
Srinivasa M. Srinivasula; Sanjeev Gupta; Pinaki Datta; ZhiJia Zhang; Ramesh Hegde; Naeun Cheong; Teresa Fernandes-Alnemri; Emad S. Alnemri